Hungary vs IDA only: Cause of death, by non-communicable diseases, male
Hungary
77.0%
in 2021
IDA only
39.8%
in 2021
Hungary rank
33rd
IDA only rank
36th
Cause of death, by non-communicable diseases, male over time
- Hungary
- IDA only
How they compare
Hungary currently reports 77.0% against 39.8% in IDA only, a difference of 37.2%.
That makes Hungary's figure about 1.9 times IDA only's.
Across all 6 years both countries report, Hungary has been ahead every year.
Hungary ranks 33rd and IDA only ranks 36th of 185 countries.
Hungary has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Hungary | IDA only | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 89.5% | 28.2% | 61.2% | Hungary |
| 2010s | 91.9% | 39.7% | 52.2% | Hungary |
| 2020s | 81.8% | 41.6% | 40.2% | Hungary |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, male, Hungary or IDA only?
- Hungary, at 77.0% against 39.8% in IDA only as of 2021.
- What is the difference in cause of death, by non-communicable diseases, male between Hungary and IDA only?
- 37.2%, with Hungary ahead.
- How many years of comparable data are there for Hungary and IDA only?
- 6 years are reported by both, from 2000 to 2021.
- How do Hungary and IDA only rank globally for cause of death, by non-communicable diseases, male?
- Hungary ranks 33rd and IDA only ranks 36th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, male (% of total male deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages due to non-communicable diseases divided by number of all male deaths ages, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.